Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
Clinical trial NCT04720131 · COMPLETED
Trial details
- NCT number
- NCT04720131
- Sponsor
- Beijing Friendship Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2023-04-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.